TY - JOUR AU - Azoulay, E. AU - Dupont, H. AU - Tabah, A. AU - Lortholary, O. AU - Stahl, J. P. AU - Francais, A. PY - 2012 DA - 2012// TI - Systemic antifungal therapy in critically ill patients without invasive fungal infection* JO - Crit Care Med VL - 40 UR - https://doi.org/10.1097/CCM.0b013e318236f297 DO - 10.1097/CCM.0b013e318236f297 ID - Azoulay2012 ER - TY - JOUR AU - Valerio, M. AU - Rodriguez-Gonzalez, C. G. AU - Munoz, P. AU - Caliz, B. AU - Sanjurjo, M. AU - Bouza, E. PY - 2014 DA - 2014// TI - Evaluation of antifungal use in a tertiary care institution: antifungal stewardship urgently needed JO - J Antimicrob Chemother VL - 69 UR - https://doi.org/10.1093/jac/dku053 DO - 10.1093/jac/dku053 ID - Valerio2014 ER - TY - JOUR AU - Nivoix, Y. AU - Launoy, A. AU - Lutun, P. AU - Moulin, J. C. AU - Phai Pang, K. A. AU - Fornecker, L. M. PY - 2012 DA - 2012// TI - Adherence to recommendations for the use of antifungal agents in a tertiary care hospital JO - J Antimicrob Chemother VL - 67 UR - https://doi.org/10.1093/jac/dks256 DO - 10.1093/jac/dks256 ID - Nivoix2012 ER - TY - JOUR AU - Apisarnthanarak, A. AU - Yatrasert, A. AU - Mundy, L. M. PY - 2010 DA - 2010// TI - Impact of education and an antifungal stewardship program for candidiasis at a Thai tertiary care center JO - Infect Control Hosp Epidemiol VL - 31 UR - https://doi.org/10.1086/653616 DO - 10.1086/653616 ID - Apisarnthanarak2010 ER - TY - JOUR AU - Sutepvarnon, A. AU - Apisarnthanarak, A. AU - Camins, B. AU - Mondy, K. AU - Fraser, V. J. PY - 2008 DA - 2008// TI - Inappropriate use of antifungal medications in a tertiary care center in Thailand: a prospective study JO - Infect Control Hosp Epidemiol VL - 29 UR - https://doi.org/10.1086/587633 DO - 10.1086/587633 ID - Sutepvarnon2008 ER - TY - JOUR AU - Dellit, T. H. AU - Owens, R. C. AU - McGowan, J. E. AU - Gerding, D. N. AU - Weinstein, R. A. AU - Burke, J. P. PY - 2007 DA - 2007// TI - Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship JO - Clin Infect Dis VL - 44 UR - https://doi.org/10.1086/510393 DO - 10.1086/510393 ID - Dellit2007 ER - TY - JOUR AU - Pappas, P. G. AU - Kauffman, C. A. AU - Andes, D. AU - Benjamin, D. K. AU - Calandra, T. F. AU - Edwards, J. E. PY - 2009 DA - 2009// TI - Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America JO - Clin Infect Dis VL - 48 UR - https://doi.org/10.1086/596757 DO - 10.1086/596757 ID - Pappas2009 ER - TY - JOUR AU - Walsh, T. J. AU - Anaissie, E. J. AU - Denning, D. W. AU - Herbrecht, R. AU - Kontoyiannis, D. P. AU - Marr, K. A. PY - 2008 DA - 2008// TI - Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America JO - Clin Infect Dis VL - 46 UR - https://doi.org/10.1086/525258 DO - 10.1086/525258 ID - Walsh2008 ER - TY - JOUR AU - Cornely, O. A. AU - Bassetti, M. AU - Calandra, T. AU - Garbino, J. AU - Kullberg, B. J. AU - Lortholary, O. PY - 2012 DA - 2012// TI - ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients JO - Clin Microbiol Infect VL - 18 UR - https://doi.org/10.1111/1469-0691.12039 DO - 10.1111/1469-0691.12039 ID - Cornely2012 ER - TY - JOUR AU - El-Ebiary, M. AU - Torres, A. AU - Fabregas, N. AU - Bellacasa, J. P. AU - Gonzalez, J. AU - Ramirez, J. PY - 1997 DA - 1997// TI - Significance of the isolation of Candida species from respiratory samples in critically ill, non-neutropenic patients. An immediate postmortem histologic study JO - Am J Respir Crit Care Med VL - 156 UR - https://doi.org/10.1164/ajrccm.156.2.9612023 DO - 10.1164/ajrccm.156.2.9612023 ID - El-Ebiary1997 ER - TY - JOUR AU - Eggimann, P. AU - Francioli, P. AU - Bille, J. AU - Schneider, R. AU - Wu, M. M. AU - Chapuis, G. PY - 1999 DA - 1999// TI - Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients JO - Crit Care Med VL - 27 UR - https://doi.org/10.1097/00003246-199906000-00019 DO - 10.1097/00003246-199906000-00019 ID - Eggimann1999 ER - TY - JOUR AU - Garbino, J. AU - Lew, D. P. AU - Romand, J. A. AU - Hugonnet, S. AU - Auckenthaler, R. AU - Pittet, D. PY - 2002 DA - 2002// TI - Prevention of severe Candida infections in nonneutropenic, high-risk, critically ill patients: a randomized, double-blind, placebo-controlled trial in patients treated by selective digestive decontamination JO - Intensive Care Med VL - 28 UR - https://doi.org/10.1007/s00134-002-1540-y DO - 10.1007/s00134-002-1540-y ID - Garbino2002 ER - TY - JOUR AU - Jacobs, S. AU - Price Evans, D. A. AU - Tariq, M. AU - Al Omar, N. F. PY - 2003 DA - 2003// TI - Fluconazole improves survival in septic shock: a randomized double-blind prospective study JO - Crit Care Med VL - 31 UR - https://doi.org/10.1097/01.CCM.0000074724.71242.88 DO - 10.1097/01.CCM.0000074724.71242.88 ID - Jacobs2003 ER - TY - JOUR AU - Pelz, R. K. AU - Hendrix, C. W. AU - Swoboda, S. M. AU - Diener-West, M. AU - Merz, W. G. AU - Hammond, J. PY - 2001 DA - 2001// TI - Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients JO - Ann Surg VL - 233 UR - https://doi.org/10.1097/00000658-200104000-00010 DO - 10.1097/00000658-200104000-00010 ID - Pelz2001 ER - TY - JOUR AU - Playford, E. G. AU - Eggimann, P. AU - Calandra, T. PY - 2008 DA - 2008// TI - Antifungals in the ICU JO - Curr Opin Infect Dis VL - 21 UR - https://doi.org/10.1097/QCO.0b013e3283177967 DO - 10.1097/QCO.0b013e3283177967 ID - Playford2008 ER - TY - JOUR AU - Slavin, M. A. AU - Sorrell, T. C. AU - Marriott, D. AU - Thursky, K. A. AU - Nguyen, Q. AU - Ellis, D. H. PY - 2010 DA - 2010// TI - Candidaemia in adult cancer patients: risks for fluconazole-resistant isolates and death JO - J Antimicrob Chemother VL - 65 UR - https://doi.org/10.1093/jac/dkq053 DO - 10.1093/jac/dkq053 ID - Slavin2010 ER - TY - JOUR AU - Garnacho-Montero, J. AU - Diaz-Martin, A. AU - Garcia-Cabrera, E. AU - Ruiz Perez de Pipaon, M. AU - Hernandez-Caballero, C. AU - Aznar-Martin, J. PY - 2010 DA - 2010// TI - Risk factors for fluconazole-resistant candidemia JO - Antimicrob Agents Chemother VL - 54 UR - https://doi.org/10.1128/AAC.00479-10 DO - 10.1128/AAC.00479-10 ID - Garnacho-Montero2010 ER - TY - JOUR AU - Ostrosky-Zeichner, L. AU - Sable, C. AU - Sobel, J. AU - Alexander, B. D. AU - Donowitz, G. AU - Kan, V. PY - 2007 DA - 2007// TI - Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting JO - Eur J Clin Microbiol Infect Dis VL - 26 UR - https://doi.org/10.1007/s10096-007-0270-z DO - 10.1007/s10096-007-0270-z ID - Ostrosky-Zeichner2007 ER - TY - JOUR AU - Kumar, A. AU - Ellis, P. AU - Arabi, Y. AU - Roberts, D. AU - Light, B. AU - Parrillo, J. E. PY - 2009 DA - 2009// TI - Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock JO - Chest VL - 136 UR - https://doi.org/10.1378/chest.09-0087 DO - 10.1378/chest.09-0087 ID - Kumar2009 ER - TY - JOUR AU - Morrell, M. AU - Fraser, V. J. AU - Kollef, M. H. PY - 2005 DA - 2005// TI - Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality JO - Antimicrob Agents Chemother VL - 49 UR - https://doi.org/10.1128/AAC.49.9.3640-3645.2005 DO - 10.1128/AAC.49.9.3640-3645.2005 ID - Morrell2005 ER - TY - JOUR AU - Kollef, M. AU - Micek, S. AU - Hampton, N. AU - Doherty, J. A. AU - Kumar, A. PY - 2012 DA - 2012// TI - Septic shock attributed to Candida infection: importance of empiric therapy and source control JO - Clin Infect Dis VL - 54 UR - https://doi.org/10.1093/cid/cis305 DO - 10.1093/cid/cis305 ID - Kollef2012 ER - TY - JOUR AU - Garey, K. W. AU - Rege, M. AU - Pai, M. P. AU - Mingo, D. E. AU - Suda, K. J. AU - Turpin, R. S. PY - 2006 DA - 2006// TI - Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study JO - Clin Infect Dis VL - 43 UR - https://doi.org/10.1086/504810 DO - 10.1086/504810 ID - Garey2006 ER - TY - JOUR AU - Mermel, L. A. AU - Allon, M. AU - Bouza, E. AU - Craven, D. E. AU - Flynn, P. AU - O'Grady, N. P. PY - 2009 DA - 2009// TI - Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America JO - Clin Infect Dis VL - 49 UR - https://doi.org/10.1086/599376 DO - 10.1086/599376 ID - Mermel2009 ER - TY - JOUR AU - Zilberberg, M. D. AU - Kollef, M. H. AU - Arnold, H. AU - Labelle, A. AU - Micek, S. T. AU - Kothari, S. PY - 2010 DA - 2010// TI - Inappropriate empiric antifungal therapy for candidemia in the ICU and hospital resource utilization: a retrospective cohort study JO - BMC Infect Dis VL - 10 UR - https://doi.org/10.1186/1471-2334-10-150 DO - 10.1186/1471-2334-10-150 ID - Zilberberg2010 ER - TY - JOUR AU - Labelle, A. J. AU - Micek, S. T. AU - Roubinian, N. AU - Kollef, M. H. PY - 2008 DA - 2008// TI - Treatment-related risk factors for hospital mortality in Candida bloodstream infections JO - Crit Care Med VL - 36 UR - https://doi.org/10.1097/CCM.0b013e31818b3477 DO - 10.1097/CCM.0b013e31818b3477 ID - Labelle2008 ER - TY - JOUR AU - Clancy, C. J. AU - Yu, V. L. AU - Morris, A. J. AU - Snydman, D. R. AU - Nguyen, M. H. PY - 2005 DA - 2005// TI - Fluconazole MIC and the fluconazole dose/MIC ratio correlate with therapeutic response among patients with candidemia JO - Antimicrob Agents Chemother VL - 49 UR - https://doi.org/10.1128/AAC.49.8.3171-3177.2005 DO - 10.1128/AAC.49.8.3171-3177.2005 ID - Clancy2005 ER - TY - JOUR AU - Pai, M. P. AU - Turpin, R. S. AU - Garey, K. W. PY - 2007 DA - 2007// TI - Association of fluconazole area under the concentration-time curve/MIC and dose/MIC ratios with mortality in nonneutropenic patients with candidemia JO - Antimicrob Agents Chemother VL - 51 UR - https://doi.org/10.1128/AAC.00474-06 DO - 10.1128/AAC.00474-06 ID - Pai2007 ER - TY - JOUR AU - Baddley, J. W. AU - Patel, M. AU - Bhavnani, S. M. AU - Moser, S. A. AU - Andes, D. R. PY - 2008 DA - 2008// TI - Association of fluconazole pharmacodynamics with mortality in patients with candidemia JO - Antimicrob Agents Chemother VL - 52 UR - https://doi.org/10.1128/AAC.00116-08 DO - 10.1128/AAC.00116-08 ID - Baddley2008 ER - TY - JOUR AU - Rodriguez-Tudela, J. L. AU - Almirante, B. AU - Rodriguez-Pardo, D. AU - Laguna, F. AU - Donnelly, J. P. AU - Mouton, J. W. PY - 2007 DA - 2007// TI - Correlation of the MIC and dose/MIC ratio of fluconazole to the therapeutic response of patients with mucosal candidiasis and candidemia JO - Antimicrob Agents Chemother VL - 51 UR - https://doi.org/10.1128/AAC.00296-07 DO - 10.1128/AAC.00296-07 ID - Rodriguez-Tudela2007 ER - TY - JOUR AU - Pfaller, M. A. AU - Diekema, D. J. AU - Sheehan, D. J. PY - 2006 DA - 2006// TI - Interpretive breakpoints for fluconazole and Candida revisited: a blueprint for the future of antifungal susceptibility testing JO - Clin Microbiol Rev VL - 19 UR - https://doi.org/10.1128/CMR.19.2.435-447.2006 DO - 10.1128/CMR.19.2.435-447.2006 ID - Pfaller2006 ER - TY - JOUR AU - Tortorano, A. M. AU - Kibbler, C. AU - Peman, J. AU - Bernhardt, H. AU - Klingspor, L. AU - Grillot, R. PY - 2006 DA - 2006// TI - Candidaemia in Europe: epidemiology and resistance JO - Int J Antimicrob Agents VL - 27 UR - https://doi.org/10.1016/j.ijantimicag.2006.01.002 DO - 10.1016/j.ijantimicag.2006.01.002 ID - Tortorano2006 ER - TY - JOUR AU - Guinea, J. AU - Pelaez, T. AU - Rodriguez-Creixems, M. AU - Torres-Narbona, M. AU - Munoz, P. AU - Alcala, L. PY - 2009 DA - 2009// TI - Empirical treatment of candidemia in intensive care units: fluconazole or broad-spectrum antifungal agents? JO - Med Mycol VL - 47 UR - https://doi.org/10.1080/13693780802415556 DO - 10.1080/13693780802415556 ID - Guinea2009 ER - TY - JOUR AU - Munoz, P. AU - Fernandez-Turegano, C. P. AU - Alcala, L. AU - Rodriguez-Creixems, M. AU - Pelaez, T. AU - Bouza, E. PY - 2002 DA - 2002// TI - Frequency and clinical significance of bloodstream infections caused by C albicans strains with reduced susceptibility to fluconazole JO - Diagn Microbiol Infect Dis VL - 44 UR - https://doi.org/10.1016/S0732-8893(02)00432-7 DO - 10.1016/S0732-8893(02)00432-7 ID - Munoz2002 ER - TY - JOUR AU - Pfaller, M. A. AU - Messer, S. A. AU - Woosley, L. N. AU - Jones, R. N. AU - Castanheira, M. PY - 2013 DA - 2013// TI - Echinocandin and triazole antifungal susceptibility profiles for clinical opportunistic yeast and mold isolates collected from 2010 to 2011: application of new CLSI clinical breakpoints and epidemiological cutoff values for characterization of geographic and temporal trends of antifungal resistance JO - J Clin Microbiol VL - 51 UR - https://doi.org/10.1128/JCM.00308-13 DO - 10.1128/JCM.00308-13 ID - Pfaller2013 ER - TY - JOUR AU - Bassetti, M. AU - Marchetti, M. AU - Chakrabarti, A. AU - Colizza, S. AU - Garnacho-Montero, J. AU - Kett, D. H. PY - 2013 DA - 2013// TI - A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts JO - Intensive Care Med VL - 39 UR - https://doi.org/10.1007/s00134-013-3109-3 DO - 10.1007/s00134-013-3109-3 ID - Bassetti2013 ER - TY - JOUR AU - Pea, F. PY - 2013 DA - 2013// TI - Current pharmacological concepts for wise use of echinocandins in the treatment of Candida infections in septic critically ill patients JO - Expert Rev Anti Infect Ther VL - 11 UR - https://doi.org/10.1586/14787210.2013.836058 DO - 10.1586/14787210.2013.836058 ID - Pea2013 ER - TY - JOUR AU - Deshpande, A. AU - Gaur, S. AU - Bal, A. M. PY - 2013 DA - 2013// TI - Candidaemia in the non-neutropenic patient: a critique of the guidelines JO - Int J Antimicrob Agents VL - 42 UR - https://doi.org/10.1016/j.ijantimicag.2013.06.005 DO - 10.1016/j.ijantimicag.2013.06.005 ID - Deshpande2013 ER - TY - JOUR AU - Bouza, E. AU - Guinea, J. AU - Pelaez, T. AU - Perez-Molina, J. AU - Alcala, L. AU - Munoz, P. PY - 2005 DA - 2005// TI - Workload due to Aspergillus fumigatus and significance of the organism in the microbiology laboratory of a general hospital JO - J Clin Microbiol VL - 43 UR - https://doi.org/10.1128/JCM.43.5.2075-2079.2005 DO - 10.1128/JCM.43.5.2075-2079.2005 ID - Bouza2005 ER - TY - JOUR AU - Herbrecht, R. AU - Denning, D. W. AU - Patterson, T. F. AU - Bennett, J. E. AU - Greene, R. E. AU - Oestmann, J. W. PY - 2002 DA - 2002// TI - Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis JO - N Engl J Med VL - 347 UR - https://doi.org/10.1056/NEJMoa020191 DO - 10.1056/NEJMoa020191 ID - Herbrecht2002 ER - TY - JOUR AU - Cornely, O. A. AU - Maertens, J. AU - Bresnik, M. AU - Ebrahimi, R. AU - Ullmann, A. J. AU - Bouza, E. PY - 2007 DA - 2007// TI - Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial) JO - Clin Infect Dis VL - 44 UR - https://doi.org/10.1086/514341 DO - 10.1086/514341 ID - Cornely2007 ER - TY - JOUR AU - Munoz, P. AU - Guinea, J. AU - Narbona, M. T. AU - Bouza, E. PY - 2008 DA - 2008// TI - Treatment of invasive fungal infections in immunocompromised and transplant patients: AmBiLoad trial and other new data JO - Int J Antimicrob Agents VL - 32 UR - https://doi.org/10.1016/S0924-8579(08)70013-X DO - 10.1016/S0924-8579(08)70013-X ID - Munoz2008 ER - TY - JOUR AU - Walsh, T. J. AU - Pappas, P. AU - Winston, D. J. AU - Lazarus, H. M. AU - Petersen, F. AU - Raffalli, J. PY - 2002 DA - 2002// TI - Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever JO - N Engl J Med VL - 346 UR - https://doi.org/10.1056/NEJM200201243460403 DO - 10.1056/NEJM200201243460403 ID - Walsh2002 ER - TY - JOUR AU - Perfect, J. R. AU - Marr, K. A. AU - Walsh, T. J. AU - Greenberg, R. N. AU - DuPont, B. AU - Torre-Cisneros, J. PY - 2003 DA - 2003// TI - Voriconazole treatment for less-common, emerging, or refractory fungal infections JO - Clin Infect Dis VL - 36 UR - https://doi.org/10.1086/374557 DO - 10.1086/374557 ID - Perfect2003 ER - TY - JOUR AU - Smith, J. AU - Andes, D. PY - 2008 DA - 2008// TI - Therapeutic drug monitoring of antifungals: pharmacokinetic and pharmacodynamic considerations JO - Ther Drug Monit VL - 30 UR - https://doi.org/10.1097/FTD.0b013e318167d0e0 DO - 10.1097/FTD.0b013e318167d0e0 ID - Smith2008 ER - TY - JOUR AU - Pasqualotto, A. C. AU - Xavier, M. O. AU - Andreolla, H. F. AU - Linden, R. PY - 2010 DA - 2010// TI - Voriconazole therapeutic drug monitoring: focus on safety JO - Expert Opin Drug Saf VL - 9 UR - https://doi.org/10.1517/14740330903485637 DO - 10.1517/14740330903485637 ID - Pasqualotto2010 ER - TY - JOUR AU - Pascual, A. AU - Csajka, C. AU - Buclin, T. AU - Bolay, S. AU - Bille, J. AU - Calandra, T. PY - 2012 DA - 2012// TI - Challenging recommended oral and intravenous voriconazole doses for improved efficacy and safety: population pharmacokinetics-based analysis of adult patients with invasive fungal infections JO - Clin Infect Dis VL - 55 UR - https://doi.org/10.1093/cid/cis437 DO - 10.1093/cid/cis437 ID - Pascual2012 ER - TY - JOUR AU - Pascual, A. AU - Calandra, T. AU - Bolay, S. AU - Buclin, T. AU - Bille, J. AU - Marchetti, O. PY - 2008 DA - 2008// TI - Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes JO - Clin Infect Dis VL - 46 UR - https://doi.org/10.1086/524669 DO - 10.1086/524669 ID - Pascual2008 ER - TY - JOUR AU - McQuillen, D. P. AU - Petrak, R. M. AU - Wasserman, R. B. AU - Nahass, R. G. AU - Scull, J. A. AU - Martinelli, L. P. PY - 2008 DA - 2008// TI - The value of infectious diseases specialists: non-patient care activities JO - Clin Infect Dis VL - 47 UR - https://doi.org/10.1086/592067 DO - 10.1086/592067 ID - McQuillen2008 ER -